Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
--------
Question: The sprawling Southeast Asian country of more than 260 million people has not recorded any cases though some of its citizens overseas have contracted the virus, including eight crew on the Diamond Princess cruise liner off Japan’s Yokohama. Health Minister Terawan Agus Putranto said 134 test samples taken from people suspected of having the coronavirus had  turned out negative. “If until this second all came out negative, then it’s a blessing from the Almighty,” he told reporters. Putranto said tests on two patients who died this week after suffering symptoms associated with contracting the virus had been negative. On Feb. 23, a Singaporean man died after reportedly suffering fever and shortness of breath in the city of Batam, but the head of the local health agency said this was due to another unspecified disease. The death of a 37-year-old man in Semarang in Central Java who was suffering pneumonia after returning from overseas was not caused by the coronavirus, but by H1N1 flu, he said. Researchers at the Harvard T.H. Chan School of Public Health, in the United States, said in a study this month that Indonesia should strengthen outbreak surveillance and control - especially as it had direct flights from the central Chinese city of Wuhan, the epicenter of the outbreak. The Harvard team said Indonesia’s lack of confirmed cases “may suggest the potential for undetected cases” as air travel may contribute to cases being exported from China. Indonesia has barred entry to visitors who have been in China for 14 days and stopped all flights to and from there. Indonesia has tested relatively few people in comparison to some neighbors and its population, but Putranto said tests were conducted when “doctors determine they have symptoms that point to that direction.”   “Imagine if everybody who had a cough or flu was checked, then millions would be checked,” he said. Navaratnasamy Paranietharan, the World Health Organization’s Indonesia representative, has said the WHO was “quite confident that Indonesia is ready to be able to respond to this situation.”  Separately, Indonesia will send a Garuda Indonesia (GIAA.JK) plane in the next few days to Japan to pick up 68 of its citizens working aboard the coronavirus-affected Diamond Princess, officials said. The crew could be quarantined for up to 28 days on Sebaru island in the Java Sea north off Jakarta, where 188 crew members from another cruise ship are also being held in quarantine. The coronavirus has infected more than 80,000 people globally and killed nearly 2,800, the majority in China.

Answer: Indonesia says lack of coronavirus cases a blessing from God.


Question: There are four slashes among the women’s siblings, others among her immediate family, and most family members’ symbols are partially colored in. Each partially filled circle represents a cancer diagnosis. Each slash indicates a death. Although white women get breast cancer more frequently, it’s usually diagnosed later and is more severe in African American women. Breast cancer death rates among black women were about 40 percent higher than among white women between 1999 and 2013, according to the Centers for Disease Control. Ricks-Santi, director of the Hampton University Cancer Research Center, and another Hampton colleague, John McDonald, recently received a $446,000 grant from the National Institutes of Health to study the genetics behind breast cancer diagnoses in African American women. In particular, they’re trying to refine genetic tests that don’t seem to be as effective for black women as white. “I wanted to make sure that there was equity in the way that genetics and genomics was being applied across populations,” Ricks-Santi said. She has a longstanding interest in cancer research, dating back to when she was a kid. Her family has a history of cancer; her father has prostate cancer. That led her to pursue an undergraduate degree at Hampton University and a Ph.D. from Georgetown University. She worked as a post-doctoral fellow in a joint cancer studies program between Georgetown and Howard University. There, she saw a trend among genetic tests for breast cancer, particularly the most common ones, BRCA 1 and 2. They are sometimes an indicator for some of the hardest to treat forms, and they’re also correlated with other kinds of cancer in men and women. At Georgetown’s cancer center, which Ricks-Santi said served mostly white and affluent patients, BRCA tests often helped doctors decide if women were candidates for preventative treatment or if they needed additional testing. At Howard’s cancer center, which served more black patients, BRCA tests often came back inconclusive. This, Ricks-Santi said, makes it hard for oncologists to come up with specific, informed approaches for patients of color. “You can’t do that if you’re not identifying the right risk factor, the right gene,” said Melissa Gomes, a mental health nurse practitioner and a co-investigator on the study. “You can’t make that personalized approach if it wasn’t based on a population that included you.” The study that Ricks-Santi and McDonald are leading uses family history and genetic data from 300 breast cancer patients at Howard, along with relatives without cancer diagnoses and other types of cancer. Ricks-Santi will conduct statistical research to find candidate genes that could provide a better test. McDonald, an assistant professor of physics, will then conduct the laboratory phase of the study, injecting those genes into cancer cells in Petri dishes to determine exactly what kind of effect those have. They’re also working with Hampton University students on the project, who will be paid with grant money. “It’s nice to create that pipeline of researchers that look like the population we want to study,” Gomes said. This round of funding lasts for three years. But they’re already looking toward the next phase. That’s where Gomes’ experience comes in, whose background is clinical psychiatry. She sees patients four days a week. In a second study, once they’ve isolated some possible genes, they want to control for those genes and then investigate social circumstances that might contribute to breast and other kinds of cancer. Gomes hopes to use her background in psychiatry and patient care to help build connections in Hampton Roads in addition to helping with the social research. “Nurses are considered one of the most trusted health professionals,” Gomes said. “I think that the community trusts us and they value their opinion.” Ricks-Santi is hopeful about this holistic approach, citing her father’s own experience. Because of the small size of his tumor, they took a more wait-and-see approach to treatment. He moved to Puerto Rico for six months to relax. It seemed to work. His prostate-specific antigen levels, an indicator of that kind of cancer, dropped significantly and have stayed stable. “It’s scary and exciting,” Ricks-Santi said. “There’s so many possibilities.” ___ Information from: Daily Press, http://www.dailypress.com/

Answer: University studies cancer risk and testing for black women.


Question: The U.S. Food and Drug Administration questioned the differences in size and formulation of the patch used in trials and the to-be-marketed patch. The generic drugs maker, which received a “complete response letter” from the FDA, said it planned to work closely with the agency to address the questions. Such letters typically lay out FDA concerns that need to be addressed before a treatment is approved. Actavis’ contraceptive skin patch is designed to provide continuous delivery of the hormone norethindrone, a type of progestin, during a once-weekly, seven-day dosing regimen. Progestin, the synthetic form of female sex hormone progestogen, inhibits ovulation and thickens the layer of mucus at the cervix so sperm cannot enter the uterus. The treatment will compete with Johnson and Johnson’s Ortho Evra, an estrogen/progestin combination contraceptive patch. Estrogen is another female sex hormone. A progestin-only patch can be safer than combination patches as high levels of estrogen are often linked to blood clotting disorders and an increased risk of cancer. The company also filed on Tuesday an application to market the generic version of Merck & Co Inc’s NuvaRing, a estrogen/progestin combination hormonal contraceptive vaginal ring. Actavis said it may be the first applicant to file the application, which, if approved may entitle it to 180 days of generic market exclusivity. Shares of Dublin, Ireland-based Actavis were down 0.6 percent at $165.16 in early trading on the New York Stock Exchange on Tuesday.

Answer:
FDA rejects Actavis' contraceptive patch, seeks more data.